The cause of Parkinson's Disease remains largely unknown, but a new drug could be extremely beneficial to treat symptoms.

More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from ...

Exercise is known as one of the best weapons in limiting the effects of the disease and creating dopamine that is low for ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

A novel drug molecule could potentially lead to new treatments to prevent Parkinson's disease in younger patients, according to new research.

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

Increased exposure to air pollution in the form of particulate matter with a diameter of 2.5 µm or less (PM2.5) and nitrogen ...

A new study shows that coffee is among the most commonly used "natural health products" used by people with Parkinson's ...

An intelligent self-adjusting brain pacemaker could improve the quality-of-life for those living with Parkinson’s disease ...

It could be a medical condition called essential tremor, and a new study by Singapore’s National Neuroscience Institute has ...

Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...

Discover promising biotech candidates and groundbreaking research offering new hope for treating mitochondrial diseases.